6,7-dimethoxy-1-[3-(3-nitro-phenyl)-piperazin-1-yl]-isoquinoline-4-carbonitrile | 1130983-53-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: 6,7-dimethoxy-1-[3-(3-nitro-phenyl)-piperazin-1-yl]-isoquinoline-4-carbonitrile
• 英文别名: 6,7-Dimethoxy-1-[3-(3-nitrophenyl)piperazin-1-yl]isoquinoline-4-carbonitrile
• CAS: 1130983-53-7
• 化学式: C₂₂H₂₁N₅O₄
• 分子量: 419.44
• InChiKey: HIUOSXISMBGZQC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  31
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  116
• 氢给体数：
  1
• 氢受体数：
  8

文献信息

• CYANOISOQUINOLINE
  申请人：Kehler Jan

  公开号：US20090075988A1

  公开（公告）日：2009-03-19

  This invention is directed to compounds, which are PDE10A enzyme inhibitors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. The present invention also provides a process for the preparation of the compounds of formula I. The present invention further provides a method of treating a subject suffering from a neurodegenerative disorder comprising administering to the subject a therapeutically effective amount of a compound of formula I. The present invention further provides a method of treating a subject suffering from a psychiatric disorder comprising administering to the subject a therapeutically effective amount of a compound of formula I.

  本发明涉及一种PDE10A酶抑制剂化合物。该发明提供了一种含有本发明化合物的治疗有效量和药学可接受载体的制药组合物。本发明还提供了一种制备式I化合物的方法。本发明还提供了一种治疗神经退行性疾病的方法，包括向受试者注射式I化合物的治疗有效量。本发明还提供了一种治疗精神障碍的方法，包括向受试者注射式I化合物的治疗有效量。
• [EN] CYANOISOQUINOLINE<br/>[FR] CYANOISOQUINOLÉINE
  申请人：LUNDBECK & CO AS H

  公开号：WO2009036766A1

  公开（公告）日：2009-03-26

  This invention is directed to compounds, which are PDE10A enzyme inhibitors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. The present invention also provides a process for the preparation of the compounds of formula (I). The present invention further provides a method of treating a subject suffering from a neurodegenerative disorder comprising administering to the subject a therapeutically effective amount of a compound of formula (I). The present invention further provides a method of treating a subject suffering from a psychiatric disorder comprising administering to the subject a therapeutically effective amount of a compound of formula (I).

  本发明涉及一种PDE10A酶抑制剂化合物。该发明提供了一种药物组合物，包括本发明化合物的治疗有效量和药学上可接受的载体。本发明还提供了一种制备式(I)化合物的方法。本发明还提供了一种治疗神经退行性疾病的方法，包括向患者施用式(I)化合物的治疗有效量。本发明还提供了一种治疗精神障碍的方法，包括向患者施用式(I)化合物的治疗有效量。
• US7858620B2
  申请人：——

  公开号：US7858620B2

  公开（公告）日：2010-12-28